Hippocratic AI
Hippocratic AI presents a platform that develops safety-focused large language models tailored for healthcare settings. The company offers AI agents designed to engage in non-diagnostic, patient-facing tasks such as preoperative preparation, post-discharge follow-up, and chronic-care management. Its architecture is built on a multi-agent system that aims to reduce clinician burden by managing routine patient interactions, while a clinician-driven test framework ensures service readiness. The service includes an “agent store” where licensed clinicians can design and deploy new agents across diverse specialties, and health systems, payers or providers can deploy them to support outreach and engagement workflows.
Founded by Munjal Shah (Co-Founder & CEO), Meenesh Bhimani (Co-Founder & Chief Medical Officer), Vishal Parikh (Co-Founder & Chief Product Officer), Subho Mukherjee (Co-Founder & Chief Science Officer), Saad Godil (Co-Founder & CTO), Kim Parikh (Co-Founder)
| Round | Announced | Raised | Post-money |
|---|---|---|---|
| Series C | Nov 3, 2025 | $126M | $3.5B |
| Series B | Jan 9, 2025 | $141M | $1.6B |
| Series A | Sep 19, 2024 | $17M | — |
| Series A | Mar 18, 2024 | $53M | $500M |
| Seed | Jul 25, 2023 | $15M | $271.6M |
- AHAndreessen Horowitz
- GCGeneral Catalyst
- AVAvenir
- KPKleiner Perkins
- NVNVIDIA
- PIPremji Invest
- SASV Angel
- CACapitalG
- JDJohn Doerr
- 7V7wire Ventures
| Kind | Implied valuation | Price / share | Date |
|---|---|---|---|
| $3.6B | $27.00 | Jul 14, 2026 | |
| $3.5B | — | Jun 1, 2025 |
Invest in the private markets on Legion
Registered users see full trading activity, every investor, rankings, and live deals.
Data as of Oct 16, 2026. Valuations are estimates blended from primary and secondary-market signals — not investment advice.
